Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Anti-Arrhythmia Agents and Potassium

Research Papers that Mention the Interaction

Recently, it has been suggested that combining potassium and calcium channel blocking mechanisms reduces the proarrhythmic potential of selective class III antiarrhythmic agents.
The Journal of pharmacology and experimental therapeutics  •  2001  |  View Paper
Accompanying these antiarrhythmic actions , quinidine, procaine amide (Pronestyl), propranolol (Inderal), and potassium worsen atrioventricular block; whereas lidocaine (Xylocaine) usually does not influence nodal conduction velocity, and diphenylhydantoin accelerates this property in the atrioventricular node.
Clinical pharmacology and therapeutics  •  1970  |  View Paper
Quite a similar antagonism was demonstrated between low potassium concentration and other antiarrhythmic agents (antazoline and SU-11636), while high potassium concentration (12 mEq./L.) enhanced the depressive effects of these three drugs.
The American journal of cardiology  •  1963  |  View Paper
Although antiarrhythmic agents or deep sedation were not effective for the VF, an intravenous supplementation of potassium completely suppressed the VF with a reduction in the J‐wave amplitude.
Pacing and clinical electrophysiology : PACE  •  2012  |  View Paper
By blocking potassium outflow currents, the anti-arrhythmic drugs prolong the action potential.
European heart journal  •  2005  |  View Paper
Antiarrhythmic drugs class IA (quinidine, disopyramide), class III (sotalol, amiodarone), class IV (… blockers) used at the same time with potassium depleters diuretics or beta-blocking agents result in the inhibition of repolarization and the increased … activation potential with the risk of developing arrhythmia of the torsade de pointes types.
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego  •  2000  |  View Paper
Antiarrhythmic agents act by blocking the membrane sodium, potassium , and calcium channels, but no agent has exclusive action on a given type of channel.
American heart journal  •  1992  |  View Paper
In addition, the presence of potassium in adequate amounts is required for the effective action of many antiarrhythmic agents.
Acta medica Scandinavica. Supplementum  •  1981  |  View Paper
Even newly released anti-arrhythmic drugs , like ivabradine with HCN channel as a primary target, block the hERG potassium current in overlapping concentration interval.
Computational toxicology  •  2018  |  View Paper
The significant anti-arrhythmia action can be achieved by inhibiting ionic channels of sodium, potassium , calcium, etc.,
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine  •  2005  |  View Paper